Abstract
We present evidence for multiple independent origins of recombinant SARS-CoV-2 viruses sampled from late 2020 and early 2021 in the United Kingdom. Their genomes carry single-nucleotide polymorphisms and deletions that are characteristic of the B.1.1.7 variant of concern but lack the full complement of lineage-defining mutations. Instead, the remainder of their genomes share contiguous genetic variation with non-B.1.1.7 viruses circulating in the same geographic area at the same time as the recombinants. In four instances, there was evidence for onward transmission of a recombinant-origin virus, including one transmission cluster of 45 sequenced cases over the course of 2 months. The inferred genomic locations of recombination breakpoints suggest that every community-transmitted recombinant virus inherited its spike region from a B.1.1.7 parental virus, consistent with a transmission advantage for B.1.1.7's set of mutations.
Original language | English |
---|---|
Article number | e8 |
Pages (from-to) | 5179-5188 |
Number of pages | 19 |
Journal | Cell |
Volume | 184 |
Issue number | 20 |
Early online date | 17 Aug 2021 |
DOIs | |
Publication status | Published - 30 Sept 2021 |
Bibliographical note
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)Funder
The COG-UK Consortium is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) (MC_PC_19027), and Genome Research Limited , operating as the Wellcome Sanger Institute . O.G.P. was supported by the Oxford Martin School . J.T.M., R.M.C., N.J.L., and A.R. acknowledge the support of the Wellcome Trust (Collaborators Award 206298/Z/17/Z – ARTIC network ). D.L.R. acknowledges the support of the MRC ( MC_UU_12014/12 ) and the Wellcome Trust ( 220977/Z/20/Z ). E.S. and A.R. are supported by the European Research Council (grant agreement no. 725422 – ReservoirDOCS ). T.R.C. and N.J.L. acknowledge the support of the MRC , which provided the funding for the MRC CLIMB infrastructure used to analyze, store, and share the UK sequencing dataset ( MR/L015080/1 and MR/T030062/1 ). The samples sequenced in Wales were sequenced partly using funding provided by the Welsh Government .Funding
The COG-UK Consortium is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) (MC_PC_19027), and Genome Research Limited , operating as the Wellcome Sanger Institute . O.G.P. was supported by the Oxford Martin School . J.T.M., R.M.C., N.J.L., and A.R. acknowledge the support of the Wellcome Trust (Collaborators Award 206298/Z/17/Z – ARTIC network ). D.L.R. acknowledges the support of the MRC ( MC_UU_12014/12 ) and the Wellcome Trust ( 220977/Z/20/Z ). E.S. and A.R. are supported by the European Research Council (grant agreement no. 725422 – ReservoirDOCS ). T.R.C. and N.J.L. acknowledge the support of the MRC , which provided the funding for the MRC CLIMB infrastructure used to analyze, store, and share the UK sequencing dataset ( MR/L015080/1 and MR/T030062/1 ). The samples sequenced in Wales were sequenced partly using funding provided by the Welsh Government .
Funders | Funder number |
---|---|
Medical Research Council | |
UK Research and Innovation | |
National Institute for Health and Care Research | MC_PC_19027 |
Wellcome Trust Sanger Institute | |
University of Oxford | |
Wellcome Trust | 206298/Z/17/Z |
European Research Council | 725422 – ReservoirDOCS |
Welsh Government |
Keywords
- SARS-CoV-2
- genomics
- evolution
- recombination
- genomic epidemiology
- B.1.1.7
- variants
ASJC Scopus subject areas
- General Biochemistry,Genetics and Molecular Biology